Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Information
About this company
Key people
David Schlanger
Executive Chairman of the Board
Peter Anevski
Chief Executive Officer, Director
Mark S. Livingston
Chief Financial Officer
Melissa Cummings
Chief Operating Officer
Allison Swartz
Executive Vice President, General Counsel, Secretary
Geoffrey Clapp
Chief Product Officer
Jeffrey Gary Park
Lead Independent Director
Lloyd H. Dean
Independent Director
Kevin K. Gordon
Independent Director
Roger C. Holstein
Independent Director
Debra L. Morris
Independent Director
Click to see more
Key facts
- Shares in issue99.21m
- EPICPGNY
- ISINUS74340E1038
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- Market cap$2.30bn
- Employees675
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.